Al-Razi University Journal for Medical Sciences
https://rujms.alraziuni.edu.ye/index.php/rzjournal
<p> </p> <p>The Collage of Medical Science in corporation with the Scientific Research Center- Al-Razi University publish a new high-quality journal devoted to Medical sciences:</p> <p><strong>Al-Razi University Journal of Medical Sciences</strong></p> <p>The Editorial Board is very committed to build the Journal as one of the leading international journals in Medical sciences in the next few years. With the support of the Scientific Research Center -Al-Razi University, it is expected that a heavy resource to be channeled into the Journal to establish its international reputation. The first issue of the journal appears in early 2017 with two issues per year.</p> <p><strong><u><span lang="AR-SA">Aims and Scope</span></u></strong></p> <p>The Al-Razi University Journal of Medical Sciences (RUJMS) is a scientific, bi-annual, peer-reviewed publication that will focus on current topics of interest to the Medical community at large. The RUJMS aims to provide a forum for a broad blend of scientific and technical papers to reflect the evolving needs of the Medical sciences. The RUJMS welcomes the submission of a manuscript that meets the general criteria of significance and academic excellence. All articles published in JJBS are peer-reviewed.</p> <p><strong>Chief- in-editor: Prof. Nabil Ahmed Al-Rabeei2</strong></p> <p>Email: nabil_alrabeei@alraziuni.edu.ye</p> <h3 class="LC20lb DKV0Md"><strong><span dir="ltr">Managing editor: Assoc. Prof. Mohammed Sadeg Al-Awar</span></strong></h3> <p><span dir="ltr">Email.momed.sadeg@gmail.com</span></p> <p><strong>Full Journal Title </strong>:</p> <p>Al-Razi University Journal for Medical Sciences (RUJMS)</p> <p><strong>Organization</strong> :</p> <p>College of medical sciences, Al-Razi University ,Sana'a, Yemen</p> <p><strong>Publisher</strong> :</p> <p>Research Center- Al-Razi University</p> <p><strong>Aim & Scope:</strong></p> <p>Al-Razi University Journal for Medical Sciences (RUJMS) is the official journal of Al-Razi University, which is published quarterly. RUJMS is an open access online and a peer-reviewed journal, which is aimed to serve as scientific research journal related to medical and health sciences. The emphasis will be on publishing quality papers rapidly and freely available to researchers worldwide.</p> <p><strong>Publishing Approval</strong> :</p> <p>Approved by the Ministry of Higher Education and Scientific Research in the ministerial decree No. (57) for the year 2018 within the approved journals for the purposes of scientific research and the adoption of published research for scientific promotion</p> <p><strong>Scientific Research Approval :</strong></p> <p>The Yemen committee of medical science journals of ministry of health and population according to certificate on 2016 as scientific research medical journal.</p> <p><strong>Content Coverage :</strong></p> <p>RUJMS is an authoritative clinical source which its content is devoted to particular compilation of the latest worldwide and interdisciplinary approach and findings including original articles, meta-analyses, case report and review articles, and letters in all areas of medical and health sciences (medicine, nursing, public health, community medicine, pharmacy, medical laboratory, anesthesia, physiotherapy, midwifery). The emphasis will be on publishing quality papers rapidly and freely available to researchers worldwide.</p> <p><strong>Abbreviation Title :</strong></p> <p>Al-Razi Un. J. Med Sci.</p> <p><strong>Category :</strong></p> <p>Medical and health sciences.</p> <p><strong>Language :</strong></p> <p>English</p> <p><strong>Journal Country:</strong></p> <p>Yemen</p> <p><strong>Frequency:</strong></p> <p>Quarterly</p> <p><strong>Online Submission:</strong></p> <p><a href="http://alraziuni.edu.ye/rujms/">http://alraziuni.edu.ye/rujms/</a></p> <p><strong>Review Process :</strong></p> <p>All manuscripts will experience an extensive single-blind peer-review process.</p> <p> </p> <p>Copy right of articles published in the RUJMS belong to the Al-Razi University- unless the work is subject to copyright. It is the responsibility of the author (s) to advise the Editor in Chief of any circumstances affecting the transfer of copyright or involving conflict of interest.</p> <h3>Section Policies</h3> <h4>Articles</h4> <table width="84%"> <tbody> <tr> <td width="30%"> <p> Open Submissions</p> </td> <td width="24%"> <p> Indexed</p> </td> <td width="43%"> <p> Peer Reviewed</p> </td> </tr> </tbody> </table> <h3>Peer Review Process</h3> <p>Articles submitted are reviewed according to highest standard by scientists specialized in their fields. The research must not have been published or offered for publication elsewhere, and the author must present a pledge to this effect.</p> <p>Open Access Policy</p> <p>This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.</p> <p><strong>Indexing/ Abstracting</strong></p> <ul> <li class="show"><strong> Ulrich's Periodicals Directory</strong></li> <li class="show"><strong> Google Scholar</strong></li> <li class="show"><strong> EBSCO</strong></li> </ul> <p><strong>Malpractice and Ethics Statement</strong></p> <p><strong>General</strong></p> <ul> <li class="show">RUJMS is committed to publishing original high quality scholarly research papers that provide solid insights into all aspects of Medical Sciences.</li> <li class="show">As a scientific refereed journal, RUJMS follows a standard process of a stringent double-blind review process. Significant guidelines are provided to reviewers so as to ensure high value and original publications.</li> <li class="show">A RUJMS Transfer of Copyright form that each author must sign to acknowledge that the paper is original, is not submitted elsewhere, and does not include copyrighted elements.</li> <li class="show">In case of plagiarism, misuse of published articles, and/or illegal distribution of research papers are proven, RUJMS is very aggressive in the legal actions it takes so as to prevent such unethical action.</li> </ul> <p><strong>Duties of Editors</strong></p> <p> </p> <ul> <li class="show">Determine whether a submitted manuscript is appropriate and within the scope of the Journal.</li> <li class="show">Select expert reviewers (i.e., referees) and an area editor to evaluate the submitted manuscript.</li> <li class="show">Render a final editorial decision on each manuscript based on journal priorities, other similar manuscripts in process and related considerations.</li> <li class="show">Communicate directly with the author and the review team.</li> <li class="show">Schedule accepted manuscripts for publication.</li> <li class="show">Balance workloads for the area editors and reviewers.</li> <li class="show">Resolve any conflicts.</li> </ul> <p>Fair Play:The editors should evaluate manuscripts for their intellectual content without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors.</p> <p>Confidentiality: The editors and any editorial staff must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.</p> <p>Disclosure and conflicts of interest: Unpublished materials disclosed in a submitted manuscript must not be used in an editor's own research without the express written consent of the author. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage.</p> <p>Involvement and cooperation in investigations: The editors should take reasonably responsive measures when ethical complaints have been presented concerning a submitted manuscript or published paper.</p> <p><strong>Duties of Reviewers</strong><br> <br> <strong>Contribution to editorial decisions: </strong>Peer review assists the editor in making editorial decisions and through the editorial communications with the author may also assist the author in improving the paper. Peer review is an essential component of formal scholarly communication, and lies at the heart of the scientific method.<br> <br> <strong>Promptness:</strong>Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and excuse himself from the review process.<br> <br> <strong>Confidentiality: </strong>Any manuscripts received for review must be treated as confidential documents. They must not be shown to or discussed with others except as authorized by the editor.<br> <br> <strong>Standards of objectivity:</strong> Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments.<br> <br> <strong>Acknowledgement of sources: </strong>Reviewers should identify relevant published work that has not been cited by the authors. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation. A reviewer should also call to the editor's attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.<br> <br> <strong>Disclosure and conflict of interest: </strong>Unpublished materials disclosed in a submitted manuscript must not be used in a reviewer’s own research without the express written consent of the author.</p> <p><strong>Duties of Authors</strong><br> <br> <strong>Reporting standards:</strong>Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. A paper should contain sufficient detail and references to permit others to replicate the work.<br> <br> <strong>Data access and retention: </strong>Authors may be asked to provide the raw data in connection with a paper for editorial review.<br> <br> <strong>Originality and plagiarism:</strong> The authors should ensure that they have written entirely original works, and if the authors have used the work or words of others that this has been appropriately cited or quoted.<br> <br> <strong>Multiple, redundant or concurrent publication:</strong>An author should not in general publish manuscripts describing essentially the same research in more than one journal or primary publication.<br> <br> <strong>Acknowledgement of sources:</strong> Proper acknowledgment of the work of others must always be given. Information obtained in the course of confidential services, such as refereeing manuscripts or grant applications, must not be used without the explicit written permission of the author of the work involved in these services.<br> <br> <strong>Authorship of the paper:</strong> Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors.<br> <br> <strong>Disclosure and conflicts of interest: </strong>All authors should disclose in their manuscript any financial or other substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.<br> <br> <strong>Fundamental errors in published works:</strong> When an author discovers a significant error or inaccuracy in his/her own published work, it is the author’s obligation to promptly notify the journal editor and cooperate with the editor to retract or correct the paper.<br> <br> <strong>Duties of the Editorial Board</strong><br> <br> Editorial boards are essential and valuable resource for journals to publications because they make sure that journals are published with integrity and accuracy. These boards often include the publisher, editor-in-chief, assistant editor, advertising editor and department editors. Editorial boards of Journal are responsible for deciding which of the articles submitted to the journal should be published.</p> <p><strong>ETHICS</strong><br>The RUJMS insists on ethical practices in both human and animal experiments. Evidence of approval by a local Ethics Committee must be supplied by the authors on demand. Animal experimental procedures should be as humane as possible and the details of anesthetics and analgesics used should be clearly stated. The ethical standards of experiments must be in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans and EU Directive 2010/63/EU for animal experiments. The journal will not consider any paper which is ethically unacceptable. A statement on ethics committee permission and ethical practices must be included in all research articles under the ‘Materials and Methods’ section. Uniform Requirements for manuscripts submitted to Biomedical Journals must be observed.</p> <p><strong>Address:</strong></p> <p>College of Medical Sciences - Al-RaziUniversity</p> <p>Telefax: 406760</p> <p>Al-Rabat St - Sana'a – Yemen</p>Al-Razi Universityen-USAl-Razi University Journal for Medical Sciences2708-0870Angiographic Characteristics of Young and Older Yemeni Patients Undergoing Diagnostic Coronary Angiography at Cardiac Center in Al-Thowrah Hospital, Sana, a City-Yemen
https://rujms.alraziuni.edu.ye/index.php/rzjournal/article/view/29
<p>Background: Coronary artery disease accounts for the greatest proportion of CVDs and is one of the most common causes of death in the developed countries. Aim: to identify the risk factor and angiographic characteristics of CAD among young and older patients presented with IHD. Methods: A total of 555 patients underwent diagnostic coronary angiography were enrolled between January and June 2013. Patient admitted in ward as one-day admission and discharged 6 hours after the procedure. Demographic data, clinical findings, details of electrocardiographic and echocardiographic findings were recorded. The traditional cardiovascular risk factors (smoking, hypertension, Khat chewing, family history and diabetes mellitus, dyslipidemia) were noted. The patient included were patients with stable angina, post-myocardial infarction and pre-operative coronary angiography before valve replacement. A written consent form was signed by the patient and his or her relatives was obtained before the procedure. Results: Most of the patients in the study were diagnosed as post MI angina. High percentage of diabetes and hypertension among the older group in comparison to the younger group (P-value <0.05). 50% of the younger group were smokers in comparison to 23.8% in older group with statistically significant difference (P-value =0.000). Family history of IHD was higher in the younger age group than that in the older age group but not significant (P-value = 0.129).. Significant left main disease was more than double in younger group (3.7%) when compared older group (1.9%). about one-third of younger group had significant LAD lesion while small number of older patient had significant LAD lesion (P-value = 0.037). The involvement of RCA was significantly higher in older group than in younger group (P-value=0.001). Although the prevalence of LCX disease was higher in older than younger group (P-value = 0.59). It is found that LAD was commonly involved vessel in the young group (31.5%) in comparison to older group (1.6%) while left circumflex artery and right coronary artery was common in in the older group. Conclusion: Smoking, family history of cardiovascular diseases, and Khat chewing high in the young patients but hypertension and diabetes were high in old patients.<br><br></p>Mohammed Al-Kebsi
##submission.copyrightStatement##
2020-12-222020-12-22221110.51610/rujms2.2.2018.29Knowledge and Skills of Midwives toward Eclampsia In Public Hospitals In Sana’a, City-Yemen
https://rujms.alraziuni.edu.ye/index.php/rzjournal/article/view/28
<p>Background: Eclampsia affects 5 to 10% of all pregnancies and contributes to 10 to 15% of maternal<br>deaths worldwide. Estimated case fatality rate due to eclampsia is 14 times higher in developing<br>countries compared to developed countries. Aim: To assess the level of knowledge and skills of<br>midwives regarding management of eclampsia at public hospitals in Sana, a city. Methods: A<br>descriptive cross-sectional study was carried out from May to June 2018. Stratified random sampling<br>was administered to selected 50 midwives during the period of this study. The data was collected<br>using a self-administered questionnaire. A questionnaire was divided into 4 sections namely;<br>demographic characteristics of midwives, training information in managing eclampsia, midwifery<br>general knowledge on eclampsia, knowledge on emergency care in managing eclamptic convulsions,<br>barriers and suggestion in managing eclamptic patients. Data were analyzed using SPSS version 20.<br>Descriptive analysis, and Chi-square and ANOVA tests were used and the level of significance was<br><0.05. Informed oral consent was obtained from the participants. Results: In this study, the mean of<br>the midwives age was the 28.5 year. Above half (68%) of the midwives were unmarried. A majority<br>(88%) of midwives had a diploma degree. The mean of work experiences was 7 year. More than half<br>(60%) of midwives were not attended courses training. 60.4% of the midwives don't know about the<br>current management of Eclampsia. Staff shortage and equipment were among the major leading<br>barriers reported by midwives in managing eclampsia. Most of the midwives suggested the need to<br>have training/seminars for managing eclampsia. Conclusion: The findings of this study revealed that<br>the majority of the midwives lack enough knowledge about the management of eclampsia. There<br>should be a need for the development of in-service training programs for midwives regarding the<br>managing eclampsia.<br><br></p>rujms ojs
##submission.copyrightStatement##
2020-12-222020-12-22222210.51610/rujms2.2.2018.28Misoprostol versus Oxytocin for the Prevention of Postpartum Haemorrhage among Women in Al-Thowrah Hospital, Sana'a City, Yemen
https://rujms.alraziuni.edu.ye/index.php/rzjournal/article/view/32
<p>Background: PPH is the leading cause of direct maternal death in developing countries. PPH is a real complication that should be studied and dealt with seriously. Aim: To compare the safety and efficacy of rectal misoprostol versus intravenous oxytocin in preventing PPH. Methods: A randomized control study was done for 6 months from 1st of May to 31 of October 2017. In the labor room of the obstetric unit at AMGH in Sana’a. The subjects were included 98 women divided into two groups: group I included 51 women were received 600 μg (3 tablets) misoprostol rectally and 2ml saline in Ringers lactate intravenously as placebo. Group II: included 47 women were received 30IU intravenous oxytocin in Ringers lactate and two lactose tablets rectally as placebo. The collected data for every woman, Patient kept under close observation for 4 hours, for any vaginal bleeding, nausea, vomiting, fever, shivering and etc. Then estimated of blood loss and side effects of uterotonic drugs by direct observation. Results: Incidence of PPH in the misoprostol group 23.5% was more than that found in the oxytocin group 6.4% (p-value<0.05). Risk factors were not significantly different in the two groups, except the prior history of PPH which is more in group I. Side effects: Shivering was more incidences in group I, 54.9% than group II, and 4.3%. While nausea was found in one case 2.1% in group II and no case found in group I. Pyrexia and vomiting were not found in the two groups. Additional uterotonic TTT was used to prevent PPH, within 4 hours of observation: 17.6% of group I needed 3 tablets misoprostol rectally and 6.4% of group II needed 30IU oxytocin infusion was added to prevent PPH. Conclusion: Misoprostol 600μg given rectally is less effective to control the PPH in the management of the third stage labour.</p>Intisar Ali Mohammed
##submission.copyrightStatement##
2020-12-232020-12-232210.51610/rujms2.2.2018.32Nutritional Status and Associated Factors among Basic School children in Sana'a City-Yemen
https://rujms.alraziuni.edu.ye/index.php/rzjournal/article/view/33
<p>Background: Malnutrition is an increasing health problem among children in developing countries. Few<br>studies were conducted about school students' malnutrition in Yemen but this study focused on children in<br>this age group in Sana'a city. Aim: To assess the nutritional status of basic school children in Sana'a city.<br>.Methods: A cross-sectional study was conducted from March 2017 to May2018. A multistage random<br>sampling technique was applied to select 198 basic school students. .Data on demographic characteristics<br>of students and their parents and anthropometric measurements of students were collected using structured<br>questionnaire as face to face interview .Data was analysis using SPSS software program.. Statistical<br>significance was considered when p-value <0.05. Results :The mean + SD of students' age were 10.96 + 2<br>.59 years with (50.5% to 49.5%) male to female percentage respectively. Out of 198 basic school children<br>about 26.3% of them were underweight, 15.7% were healthy weight, 3.5% overweight and 2.5% obese<br>based on CDC growth reference standard. The distribution of the children nutritional status based on their<br>height for age showed that the majority of children were stunted 53.5%. There was strong statistically<br>significant difference between children nutritional status and their sex, mother and father education, birth<br>order. Conclusion: The most common form of malnutrition among basic school children in Sana'a city<br>was underweight at the rate of (26.3%). Sex, mother and father education, birth order were key factors<br>contributing to malnutrition in children. Nutrition education should be apply to community.</p>Afrah Al-Dubhani
##submission.copyrightStatement##
2020-12-232020-12-23224410.51610/rujms2.2.2018.33Seroprevalence of HIV, Hepatitis B and C Virus Infections Among Voluntary and Replacement Blood Donors Attending Al-Sabeen Hospital, Blood Bank, Sana' a City
https://rujms.alraziuni.edu.ye/index.php/rzjournal/article/view/34
<p>Background: Blood donation saves millions of lives. The blood donor program is the life force of any<br>transfusion service. Aim: To assess the seroprevalence of transfusion-transmissible infections (HIV,<br>HBV, and HCV) in the voluntary and replacement donors. Methods: The study included 2475 blood<br>donors both voluntary and replacement blood donors attended at the blood bank, at Al-Sabeen<br>Hospital, Sana'a, Yemen. The blood samples of all the blood donors were. Few milliliters of each<br>donor’s blood were dispensed in a small clean test tube labelled with the name and sample number for<br>mandatory screening of the Transfusion. All the blood donors' samples over the period of study were<br>centrifuged to obtain the serum samples in a small clean test tube labeled with the name and sample<br>number were analysed and tested by the immunoassay analyser assay (ELIZA) Cobas e-411 IInd<br>generation for anti HIV IgG and IgM antibodies, detection of HBsAg and anti-HCV IgG and IgM.<br>Results: The total Seroprevalence of HIV, HBsAg and HCV was 359 donors in the present study, out of<br>them 263 (14.3%) were replacement blood donors and 96 (15.2%) were voluntary blood donors. The<br>total seroprevalence of HIV among blood donors was 42 donors in the present study, out of them 1.8%<br>among replacement blood donors and 1.7% among voluntary blood donors. The total seroprevalence<br>of HBsAg among blood donors was 286 donors out of them 11.2% among replacement blood donors<br>and 12.6% of HBsAg among voluntary blood donors. The total seroprevalence of HCV among blood<br>donors was 31 donors out of them 1.3% were replacement donors and 1.1% were voluntary blood<br>donors. Conclusion: It has been observed that replacement blood donation is safe as compared to<br>voluntary as a high prevalence of HIV, HBsAg, and HCV are observed in replacement donors. It is<br>recommended to following the international standers for the blood collection criteria and screening.</p>Amal Banafa
##submission.copyrightStatement##
2020-12-232020-12-23225510.51610/rujms2.2.2018.34Urine Microalbumin and other Nephropathy Markers in Yemeni Patients with Type 2 Diabetes Mellitus
https://rujms.alraziuni.edu.ye/index.php/rzjournal/article/view/35
<p>Background: Diabetic nephropathy (DN) is a severe complication of diabetes mellitus (DM).<br>However, it can be detected early by periodic laboratory investigations in particular urine<br>microalbumin and urine albumin to creatinine ratio (ACR). Aim: To assess the levels of urine<br>microalbumin, ACR and other nephropathy markers in Yemeni diabetic type 2 patients. Methods: A<br>random sample of 50 Yemeni diabetic patients who had not to develop any signs of nephropathy was<br>included in this study. The subjects were selected during visit the DM unit at the internal medicine<br>department in Al-Thawra hospital, Sana`a-Yemen. The sample includes 36 males and 14 females. The<br>laboratory investigations were performed on early-morning samples of the subjects and included<br>random blood sugar (RBS), serum creatinine (SCr), blood urea nitrogen (BUN), ACR and urine<br>microalbumin. Results: The mean levels of the 5 tested parameters in both male and female subjects<br>were higher than normal levels. The difference in such parameters was significant between males and<br>females in SCr, BUN and urine microalbumin while found insignificant in RBS and ACR. Conclusion:<br>The levels of DN markers including urine microalbumin, ACR, SCr and BUN are high in Yemeni<br>diabetic type 2 patients which indicates a high prevalence of early stage of nephropathy. The levels of<br>urine microalbumin, SCr and BUN are significantly higher in male subjects.</p>Amal M Banafa
##submission.copyrightStatement##
2020-12-262020-12-26226610.51610/rujms2.2.2018.35